Monograph

N06BC01 - Caffeine

Propably not porphyrinogenic

PNP

Rationale

Metabolised by CYP 1A2. Widely used as beverage but no reports of porphyrinogenic effects. One reference:

Chemical description

Xantine derivative used as a stimulant and headache analgesic. Metabolized by CYP1A2. Inhibitor of CYP 1A2.

IPNet drug reports

Uneventful use reported in 1 patient with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes N06B / N06BC or go back.

Tradenames

This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Show more details and information about the listed tradenames